Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation
| Image |  |
|---|---|
| Description | scientific article published on 16 August 2014 |
| Author/s |
author: Edward A. Stadtmauer |
| Publication date | August 16, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |